title: A Motion Videogame for Opioid Relapse Prevention.
abstract: OBJECTIVE
  This study examined the feasibility and acceptability of a body motion-activated videogame, targeting the prevention of opioid relapse among youth in the context of outpatient treatment.
  
  
  METHODS
  Participants attended four weekly gameplay sessions. Surveys were conducted at baseline and following each week's gameplay and assessed satisfaction with gameplay, craving intensity, and self-efficacy to refuse opioids.
  
  
  RESULTS
  Participants expressed a high level of satisfaction with the videogame throughout the 4 weeks and agreed with the statement that they would be more likely to attend treatment sessions if the game was present (mean=4.6; standard deviation [SD]=0.7) and would recommend the videogame to other people in treatment (mean=4.2; SD=0.8). All participants recommended playing the videogame as part of treatment at least weekly, with a third recommending playing daily. Self-reported cravings declined over the 4-week period from baseline (mean=12.7; SD=8.4) to Week 4 (mean=9.8; SD=8.3), although the decline was not significant. Although participants stated that they liked the game, one-third of participants had dropped out of the study by the fourth session of gameplay.
  
  
  CONCLUSIONS
  Preliminary evidence indicates that a motion videogame for addiction recovery may be feasible and acceptable within the context of outpatient treatment, although additional efforts are needed to keep youth in treatment. Future studies are needed to assess the impact of the game on long-term abstinence, treatment adherence, and engagement.
authors.affiliation: 1 Milken Institute School of Public Health, The George Washington University , Washington, D.C.
authors.forename: Lorien C
authors.initials: LC
authors.lastname: Abroms
authors.affiliation: 1 Milken Institute School of Public Health, The George Washington University , Washington, D.C.
authors.forename: Leah E
authors.initials: LE
authors.lastname: Leavitt
authors.affiliation: 1 Milken Institute School of Public Health, The George Washington University , Washington, D.C.
authors.forename: Judy M
authors.initials: JM
authors.lastname: Van Alstyne
authors.affiliation: 1 Milken Institute School of Public Health, The George Washington University , Washington, D.C.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Schindler-Ruwisch
authors.affiliation: 2 Mountain Manor Treatment Center , Baltimore, Maryland.|3 Department of Psychiatry, Johns Hopkins University School of Medicine , Baltimore, Maryland.
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Fishman
authors.affiliation: 4 Media Rez , LLC, Washington, D.C.
authors.forename: Daniel
authors.initials: D
authors.lastname: Greenberg
mesh_terms: D000293:Adolescent; D000553:Ambulatory Care / Q000379:methods; D000701:Analgesics, Opioid / Q000009:adverse effects; D001362:Avoidance Learning; D066249:Craving; D005260:Female; D006801:Humans; D008297:Male; D010549:Personal Satisfaction; D055502:Secondary Prevention / Q000379:methods*; D020377:Self Efficacy; D057566:Self Report; D000068356:Self-Control; D019966:Substance-Related Disorders / Q000534:rehabilitation*; D018910:Video Games / Q000523:psychology*; D055815:Young Adult
chemical_list: D000701:Analgesics, Opioid